This announcement is a separate document:
啓明醫療-B：(1) 建議採納購股權計劃 (2) 建議授權董事會及/或計劃管理人 處理購股權計劃相關事宜 (3) 2023 年第二次臨時股東大會通告 (4) 2023 年第三次H股類別股東會議通告及 (5) 2023 年第三次非上市外資股類別股東會議通告
VENUS MEDTECH-B: (1) PROPOSED ADOPTION OF THE SHARE OPTION SCHEME (2) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE SCHEME ADMINISTRATOR TO HANDLE MATTERS IN RELATION TO THE SHARE OPTION SCHEME (3) NOTICE OF 2023 SECOND EXTRAORDINARY GENERAL MEETING (4) N
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.